Condition
Acute Bacterial Skin and Skin Structure Infection (ABSSSI)
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
3 treatments under study, led by Ultrasonic Drug Delivery
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Phase 1 (1)
Phase 2 (1)
Trial Status
Completed1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Showing 2 of 2 trials
NCT06394518Phase 1CompletedPrimary
Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants
NCT03732365Phase 2UnknownPrimary
Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
Showing all 2 trials
Research Network
Common Treatments
- Ultrasonic Drug Delivery1
- Standard Of Care Antibiotic Treatment1
- Tnp2092 For Injection1
Active Sponsors
- Sonescence, Inc.1
- University of Southern California1
- TenNor Therapeutics Inc.1
Top Investigators
University of Southern California
Related Conditions
- Nonhealing Wound1
- Prosthetic Joints Infection Pji1